Evidence map›Paper›PMID 33772815›Full record

ArticleAllergy2021

Real-life impact of COVID-19 pandemic lockdown on the management of pediatric and adult asthma: A survey by the EAACI Asthma Section.

Ibon Eguiluz-Gracia, Maarten van den Berge, Cristina Boccabella, Matteo Bonini, Cristiano Caruso, Mariana Couto, FerdaOner Erkekol, Maia Rukhadze, Silvia Sanchez-Garcia, Stefano Del Giacco and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Allergy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Asthma control and exacerbation risk following SARS-CoV-2 infection in the post-acute COVID-19 phase: a systematic review.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. ERS/EAACI statement on adherence to international adult asthma guidelines.European respiratory review : an official journal of the European Respiratory Society · 2021
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 11 institutions in 9 countries.

Ibon Eguiluz-GraciaAllergy Unit, Hospital Regional Universitario de Malaga, Malaga, Spain.ORCID 0000-0002-3774-931X
Maarten van den BergeGroningen Research Institute for Asthma and COPD, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.
Cristina BoccabellaDepartment of Cardiovascular and Thoracic Sciences, Fondazione PoliclinicoUniversitario "A Gemelli" - IRCCS, University of the Sacred Heart, Rome, Italy.ORCID 0000-0003-1942-8886
Matteo BoniniDepartment of Cardiovascular and Thoracic Sciences, Fondazione PoliclinicoUniversitario "A Gemelli" - IRCCS, University of the Sacred Heart, Rome, Italy.ORCID 0000-0002-3042-0765
Cristiano CarusoAllergy Unit, Fondazione Policlinico Universitario "A. Gemelli" - IRCCS, Rome, Italy.
Mariana CoutoCentro de Alergia, Hospital CUF Descobertas, Lisboa, Portugal.ORCID 0000-0003-4987-9346
FerdaOner ErkekolDivision of Allergy and Clinical Immunology, Faculty of Medicine, Ankara YildirimBeyazit University, Ankara, Turkey.ORCID 0000-0001-9155-0304
Maia RukhadzeCenter of Allergy &Immunology, Tbilisi, Georgia.
Silvia Sanchez-GarciaAllergy Department, Hospital Infantil Universitario del Niño Jesús, Madrid, Spain.
Stefano Del GiaccoAllergy and Clinical Immunology Unit, Department of Medical Sciences and Public Health, University Hospital "DuilioCasula", Monserrato (Cagliari), Italy.ORCID 0000-0002-4517-1749
Marek JutelDepartment of Clinical Immunology, Wroclaw Medical University, Wroclaw, Poland.
Ioana AgacheFaculty of Medicine, Department of Allergy and Clinical Immunology, Transylvania University Brasov, Brasov, Romania.ORCID 0000-0001-7994-364X
Istituti di Ricovero e Cura a Carattere Scientifico · ITAgostino Gemelli University Polyclinic · ITAnkara Yıldırım Beyazıt University · TRHospital do Desterro · PTHospital Infantil Universitario Niño Jesús · ESHospital Regional Universitario de Málaga · ESTransylvania University of Brașov · ROUniversity Geomedi · GEUniversity Medical Center Groningen · NLUniversity of Cagliari · ITWroclaw Medical University · PL

Funding

EAACI Position Paper
6 · The paper itself

Abstract

backgroundThe restrictions imposed by the COVID-19 pandemic impact heavily the management of chronic diseases like asthma. This study aimed to evaluate the management of adults and children with asthma during COVID-19-related lockdown.

methodsA survey was launched by the European Academy of Allergy and Clinical Immunology (EAACI) via e-mail, website, and social media to EAACI members and members of peer societies.

resultsThe survey was completed by 339 healthcare professionals from 52 countries. 79% of follow-up consultations were replaced by phone calls, whereas 49% of newly referred patients attended the clinic. 62%, 76%, 66%, 76%, and 87% of responders did not conduct spirometry, impulse oscillometry, bronchodilator test, FeNO, or methacholine provocation, respectively, for asthma diagnosis in adults. The numbers were similar for children. 73% of responders based the initial asthma diagnosis and the prescription of inhaled therapy on clinical parameters only. Lung function tests were used in 29% of cases to monitor asthma worsening, and only 56% of participants were recommended to their patients ambulatory peak expiratory flow (PEF) measurements. Using a 1 (not at all) to 5 (very much) scale, the responders considered that the quality of healthcare provided and the patients' asthma status had deteriorated during the lockdown with 3.2 points and 2.8 points, respectively.

conclusionCollectively, these results suggest that all necessary resources should be allocated to ensure the performance of lung function tests for initial diagnosis, whereas digital remote monitoring should be reinforced for the follow-up of children and adults with asthma.

Indexed as

AsthmaCOVID-19AdultChildCommunicable Disease ControlHumansPandemicsSARS-CoV-2asthmaCOVID-19 lockdownexacerbationslung function testpeak expiratory flow

Identifiers

PMID33772815
PMCPMC8250685
OpenAlexW3152116678

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.